Literature DB >> 2836046

Agents of equine viral encephalomyelitis: correlation of serum and cerebrospinal fluid antibodies.

D P Keane1, P B Little, B N Wilkie, H Artsob, J Thorsen.   

Abstract

A survey was conducted by testing 115 paired equine serum and cerebrospinal fluid samples by hemagglutination-inhibition for antibodies to Powassan and snowshoe hare viruses, and by virus neutralization for antibodies to equine herpesvirus type 1. Twenty-five samples were from horses with spontaneous neurological disease and the remainder from horses euthanized because of various nonneurological disorders. All sera and cerebrospinal fluids were negative for antibodies to Powassan virus. Fifty-one sera (44.3%) and 15 cerebrospinal fluids (13.0%) had antibodies to snowshoe hare virus. Ninety-eight sera (85.2%) and four cerebrospinal fluids (3.5%) were positive for antibodies to equine herpesvirus type 1. Powassan virus was inoculated intracerebrally into one, and intravenously into four ponies. Neurological signs associated with a nonsuppurative encephalomyelitis occurred in three ponies. Antibodies to Powassan virus were detected in sera of all animals but in cerebrospinal fluids of only two. Powassan virus was isolated from brain and spinal cord of only the intracerebrally inoculated animal.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836046      PMCID: PMC1255432     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  26 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  Investigations of the use of beta-propiolactone in virus inactivation.

Authors:  G A LOGRIPPO
Journal:  Ann N Y Acad Sci       Date:  1960-01-13       Impact factor: 5.691

3.  The central nervous system-associated immune response to parainfluenza type I virus in mice.

Authors:  W Gerhard; Y Iwasaki; H Koprowski
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

4.  Studies on equine herpesviruses. 3. The incidence in Queensland of three different equine herpesvirus infections.

Authors:  T J Bagust; R R Pascoe; T J Harden
Journal:  Aust Vet J       Date:  1972-02       Impact factor: 1.281

Review 5.  Relation of immune response to development of central nervous system lesions in virus infections of man.

Authors:  H E Webb; C E Smith
Journal:  Br Med J       Date:  1966-11-12

6.  California encephalitis virus activity in mosquitoes and horses in southern Ontario, 1975.

Authors:  H Artsob; R Wright; L Shipp; L Spence; C Th'ng
Journal:  Can J Microbiol       Date:  1978-12       Impact factor: 2.419

7.  Pathological observations on an outbreak of paralysis in broodmares.

Authors:  H Platt; H Singh; K E Whitwell
Journal:  Equine Vet J       Date:  1980-07       Impact factor: 2.888

8.  Serological study of an outbreak of paresis due to equid herpesvirus 1 (EHV-1).

Authors:  Z Dinter; B Klingeborn
Journal:  Vet Rec       Date:  1976-07-03       Impact factor: 2.695

9.  Epizootic of western encephalomyelitis virus infection in equines in Alberta in 1965.

Authors:  O Morgante; H N Vance; J A Shemanchuk; R Windsor
Journal:  Can J Comp Med       Date:  1968-04

10.  Diagnosis of eastern equine encephalomyelitis by immunofluorescent staining of brain tissue.

Authors:  T P Monath; R G McLean; C B Cropp; G L Parham; J S Lazuick; C H Calisher
Journal:  Am J Vet Res       Date:  1981-08       Impact factor: 1.156

View more
  2 in total

1.  Equine herpes virus type 1 (EHV-1) and 4 (EHV-4) infections in horses and donkeys in northeastern Turkey.

Authors:  Y Yildirim; V Yilmaz; A H Kirmizigul
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

2.  Powassan Virus and Other Arthropod-Borne Viruses in Wildlife and Ticks in Ontario, Canada.

Authors:  Kathryn Smith; Paul T Oesterle; Claire M Jardine; Antonia Dibernardo; Chris Huynh; Robbin Lindsay; David L Pearl; Angela M Bosco-Lauth; Nicole M Nemeth
Journal:  Am J Trop Med Hyg       Date:  2018-05-31       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.